ARS Pharmaceuticals Inc.

NASDAQ: SPRY · Real-Time Price · USD
14.53
0.06 (0.41%)
At close: Aug 15, 2025, 3:59 PM
14.60
0.48%
After-hours: Aug 15, 2025, 05:11 PM EDT

ARS Pharmaceuticals Revenue

ARS Pharmaceuticals reported an annual revenue of $89.15M, reflecting a 297063.33% growth. For the quarter ending June 30, 2025, ARS Pharmaceuticals generated $15.72M in revenue.
Revenue (ttm)
89.15M
Revenue Growth
297063.33%
Price / Sales Ratio
11.47
Revenue / Employee
575.15K
Employees
155
Market Cap
1.43B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.